ArticleExploration of neuroprotective therapy2021

Targeting cytochrome P450 46A1 and brain cholesterol 24-hydroxylation to treat neurodegenerative diseases.

Irina A PikulevaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.